LENZ Therapeutics

LENZ Therapeutics

A San Diego-based late-stage clinical company developing innovative ophthalmic pharmaceutical products to improve vision, with a focus on restoring presbyopia-related near vision loss.

HQ location
Solana Beach, United States
Launch date
Employees
Market cap
$849m
Enterprise value
$656m
Share price
$29.31 LENZ
Recent deals
  • Edit

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD202120222023202420252026
Revenues000000000000000000000000
% growth-----551 %
EBITDA000000000000000000000000
% EBITDA margin-(70 %)----
Profit000000000000000000000000
% profit margin-(72 %)----
EV000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget000000000000000000000000
R&D % of revenue-141 %----

Source: Company filings or news article, Equity research estimates

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by LENZ Therapeutics

Edit
Graphite Bio
ACQUISITION by LENZ Therapeutics Nov 2023